Washburn S A, Honoré E K, Cline J M, Helman M, Wagner J D, Adelman S J, Clarkson T B
Comparative Medicine Clinical Research Center, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, USA.
Am J Obstet Gynecol. 1996 Aug;175(2):341-9; discussion 349-51. doi: 10.1016/s0002-9378(96)70144-8.
Our purpose was to determine the effects of 17 alpha-dihydroequilenin on plasma lipid and lipoprotein, glucose, and insulin concentrations; coronary artery vasomotor function; and reproductive organ and mammary gland proliferation in atherosclerotic male and female rhesus macaques.
Fifty adult female and 33 adult male rhesus macaques were randomized to treatment by lifetime dietary cholesterol exposure and ratio of total plasma cholesterol to high-density lipoprotein cholesterol. The female treatment groups were intact female controls (n = 9), ovariectomized controls (n = 16), ovariectomized plus 0.3 mg/kg/day 17 alpha-dihydroequilenin (n = 17) and ovariectomized plus subcutaneous estradiol (n = 7). The male treatment groups were control (n = 16) and 1.25 mg/kg/day 17 alpha-dihydroequilenin (n = 17). Treatment lasted 5 weeks. Longitudinal assessments of plasma lipid and lipoprotein and glucose and insulin concentrations were performed. Coronary artery vasomotor function was assessed by quantitative coronary angiography 1 week after initiation of treatment. Morphologic and immunohistochemical assessments of proliferation index values of reproductive organs and mammary glands were done at necropsy.
17 alpha-Dihydroequilenin prevented endothelium-dependent vasoconstriction in males (p < 0.05) and ovariectomized females (p < 0.08). 17 alpha-Dihydroequilenin treatment increased plasma apolipoprotein A-1 concentrations (p < 0.05) and lowered fasting insulin concentrations (p < 0.05) without changing fasting plasma glucose concentrations in males. 17 alpha-Dihydroequilenin had no other effects on plasma lipid and lipoprotein concentrations in either males or females. It had no trophic effects on uterus, endometrium, or breast. There was no effect on either prostatic or testicular weight.
17 alpha-Dihydroequilenin may represent a single-agent hormone therapy for reduction of ischemic hear disease risk for both menopausal women and men. It has no apparent trophic effects on reproductive organs or mammary glands of female and male rhesus macaques.
我们的目的是确定17α-二氢马萘雌酮对动脉粥样硬化的雄性和雌性恒河猴的血浆脂质、脂蛋白、葡萄糖和胰岛素浓度、冠状动脉血管舒缩功能以及生殖器官和乳腺增殖的影响。
50只成年雌性和33只成年雄性恒河猴通过终生饮食胆固醇暴露以及总血浆胆固醇与高密度脂蛋白胆固醇的比例被随机分组接受治疗。雌性治疗组包括未切除卵巢的雌性对照(n = 9)、切除卵巢的对照(n = 16)、切除卵巢加0.3毫克/千克/天的17α-二氢马萘雌酮(n = 17)以及切除卵巢加皮下注射雌二醇(n = 7)。雄性治疗组包括对照(n = 16)和1.25毫克/千克/天的17α-二氢马萘雌酮(n = 17)。治疗持续5周。对血浆脂质、脂蛋白以及葡萄糖和胰岛素浓度进行纵向评估。在治疗开始1周后通过定量冠状动脉造影评估冠状动脉血管舒缩功能。在尸检时对生殖器官和乳腺的增殖指数值进行形态学和免疫组织化学评估。
17α-二氢马萘雌酮可预防雄性(p < 0.05)和切除卵巢的雌性(p < 0.08)的内皮依赖性血管收缩。17α-二氢马萘雌酮治疗可提高雄性血浆载脂蛋白A-1浓度(p < 0.05)并降低空腹胰岛素浓度(p < 0.05),而不改变空腹血浆葡萄糖浓度。17α-二氢马萘雌酮对雄性或雌性的血浆脂质和脂蛋白浓度没有其他影响。它对子宫、子宫内膜或乳腺没有营养作用。对前列腺或睾丸重量没有影响。
17α-二氢马萘雌酮可能是一种用于降低绝经后女性和男性缺血性心脏病风险的单药激素疗法。它对雄性和雌性恒河猴的生殖器官或乳腺没有明显的营养作用。